The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome

Clinical Rheumatology

Volumn 26, Issue 12, 2007, Pages 2109-2114

  Miesbach, W ^a   Asherson, R A ^b   Cervera, R ^c   Shoenfeld, Y ^d   Puerta, J Gomez ^c   Espinosa, G ^c   Bucciarelli, S ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c HOSPITAL CLÍNIC   (Spain)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Anti phospholipid syndrome; Carcinoma; Catastrophic; Malignancy; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PROSTACYCLIN; STEROID;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CARCINOMA; CHILD; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PLASMA EXCHANGE; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 36248972264     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0634-x     Document Type: Article

References (26)

1. Piette JC, Cervera R, Levy RA, Nasonov EL, Triplett DA, Shoenfeld Y (2000) The catastrophic antiphospholipid syndrome - Asherson's syndrome. Ann Med Interne (Paris) 154(4):195-196
2. Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19(4):508-512
3. Triplett DA, Asherson RA (2000) Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS). Am J Hematol 65(2):154-159
4. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piett JC et al (2003) Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus 12(7):530-534
5. Cervera R, Font J, Gómez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, Ramos-Casals M, Ingelmo M, Piette JC, Shoenfeld Y, Asherson RA, Catastrophic Antiphospholipid Syndrome Registry Project Group (2005) Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 64(8):1205-1209
6. Asherson RA (2000) Antiphospholipid antibodies, malignancies and paraproteinemias. J Autoimmun 15(2):117-122
7. Asherson RA, Cervera R, Piette JC et al (2001) Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80:1-23
8. Soltesz P, Szekanecz Z, Vegh J, Lakos G, Toth L, Szakall S, Veres K, Szegedi G (2000) Catastrophic antiphospholipid syndrome in cancer. Haematologica 30(4):303-311
9. Lossos IS, Bogomolski-Yahalom V, Hatzner Y (1998) Anticardiolipin antibodies in acute myeloid leukemia: Prevalence and clinical significance. Am J Hematol 57(2):139-143
10. Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A, Zaccari G, Papa G (1993) Antiphospholipid antibodies: Prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Thromb Haemost 70(4):568-572
11. Miesbach W, Scharrer I, Asherson RA (2006) Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin Rheumatol 25(6):840-844
12. Yoon KH, Wong A, Shakespeare T, Sivalingam P (2003) High prevalence of the antiphospholipid antibodies In Asian cancer patients with thrombosis. Lupus 12(2):112-116
13. Zuckerman E, Toubi E, Golan TD et al (1995) Increased thromboembolic incidence in anticardiolipin-positive patients with malignancy. Br J Cancer 72(2):447-451
14. Miesbach W, Scharrer I, Asherson RA (2007) High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma. Clin Rheumatol 26(1):95-97
15. Schved JF, Dupuy-Fons C, Biron C et al (1994) A prospective epdimiological study of the occurrence of antiphospholipid antibody: The Montpellier Antiphospholipid (MAP) Study. Haemostasis 24(3):175-182
16. Cervera R, Asherson RA, Acevedo ML, Gómez-Puerta JA, Espinosa G, De La Red G, Gil V, Ramos-Casals M, Garcia-Carrasco M, Ingelmo M, Fontr J (2004) Antiphospholipid syndrome associated with infections: Clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 63(10):1312-1317
17. Cervera R, Gómez-Puerta JA, Espinosa G, Font J, De La Red G, Gil V, Bucciarelli S et al (2003) "CAPS registry". A review of 200 cases from the international registry of patients with catastrophic antiphospholipid syndrome (CAPS). Ann Rheum Dis 62(Suppl 1):88
18. Amital H, Levy Y, Davidson C, Lundberg I, Harju A, Kosach Y, Asherson RA, Shoenfeld Y (2001) Catastrophic antiphospholipid syndrome: Remission following leg amputation in 2 cases. Semin Arthritis Rheum 31(2):127-132
19. Asherson RA, Davidge-Pitts MC, Wypkema E (2006) "Primary" antiphospholipid syndrome evolving into Waldenstrom's macroglobulinaemia: A case report. Clin Rheumatol 26(2):278-280
20. Asherson RA, Frances C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A (2006) The antiphospholipid antibody syndrome: diagnosis, skin. Clin Exp Rheumatol 24(1 Suppl 40):S46-S51
21. Pusterla S, Previtali S, Marziali S et al (2004) Antiphospholipid antibodies in lymphoma: Prevalence and clinical significance. Hematol J 5(4):341-346
22. Genvresse I, Lüftner D, Späth-Schwalbe E, Buttgereit F (2002) Prevalence and clinical significance of anticardiolipin and anti-β2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma. Eur J Haematol 68(2):84-90
23. Timuragaoglu A, Duman A, Ongut G, Saka O, Karadogan I (2000) The significance of autoantibodies in non-Hodgkin's lymphoma. Leuk Lymphoma 40(1):119-122
24. Trousseau A (1865) Phlegmasia alba dolens. In: Clinique Medical de L'Hotel Dieu de Paris, vol 3. New Sydenham Society, London, 94 p
25. Erkan D, Asherson RA, Espinosa G, Cervera R, Font J, Piette JC et al (2003) Long term outcome of catastrophic antiphospholipid survivors. Ann Rheum Dis 62(6):530-533
26. Bucciarelli S, Espinosa F, Cervera R, Erkan D, Ramos-Casals M, Lockshin MD, Font J, Asherson RA (2007) Mortality in the catastrophic antiphospholipid syndrome: Prognostic factors in a series of 250 patients. Arthritis Rheum (in press)